Home
>
National Drug Code (NDC)
>
ARIMIDEX
ARIMIDEX - 0310-0201-30 - (Anastrozole)
Drug Information of ARIMIDEX
| Product NDC: | 0310-0201 |
| Proprietary Name: | ARIMIDEX |
| Non Proprietary Name: | Anastrozole |
| Active Ingredient(s): | 1 mg/1 & nbsp; Anastrozole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ARIMIDEX
| Product NDC: | 0310-0201 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020541 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960116 |
Package Information of ARIMIDEX
| Package NDC: | 0310-0201-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0310-0201-30) |
NDC Information of ARIMIDEX
| NDC Code | 0310-0201-30 |
| Proprietary Name | ARIMIDEX |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0310-0201-30) |
| Product NDC | 0310-0201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anastrozole |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19960116 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | ANASTROZOLE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
